These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14977164)

  • 1. Volterra series in pharmacokinetics and pharmacodynamics.
    Verotta D
    J Pharmacokinet Pharmacodyn; 2003 Oct; 30(5):337-62. PubMed ID: 14977164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unifying view of wiener and volterra theory and polynomial kernel regression.
    Franz MO; Schölkopf B
    Neural Comput; 2006 Dec; 18(12):3097-118. PubMed ID: 17052160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using spline-enhanced ordinary differential equations for PK/PD model development.
    Wang Y; Eskridge K; Zhang S; Wang D
    J Pharmacokinet Pharmacodyn; 2008 Oct; 35(5):553-71. PubMed ID: 18989761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models.
    Unadkat JD; Bartha F; Sheiner LB
    Clin Pharmacol Ther; 1986 Jul; 40(1):86-93. PubMed ID: 3720181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous modeling of pharmacokinetics and pharmacodynamics: an improved algorithm.
    Verotta D; Sheiner LB
    Comput Appl Biosci; 1987 Nov; 3(4):345-9. PubMed ID: 2898970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.
    Ayyar VS; Jusko WJ
    Pharmacol Rev; 2020 Apr; 72(2):414-438. PubMed ID: 32123034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric Methods in Population Pharmacokinetics.
    Goutelle S; Woillard JB; Neely M; Yamada W; Bourguignon L
    J Clin Pharmacol; 2022 Feb; 62(2):142-157. PubMed ID: 33103785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System identification of point-process neural systems using probability based Volterra kernels.
    Sandler RA; Deadwyler SA; Hampson RE; Song D; Berger TW; Marmarelis VZ
    J Neurosci Methods; 2015 Jan; 240():179-92. PubMed ID: 25479231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiparametric mixed-effects analysis of PK/PD models using differential equations.
    Wang Y; Eskridge KM; Zhang S
    J Pharmacokinet Pharmacodyn; 2008 Aug; 35(4):443-63. PubMed ID: 18781382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using stochastic differential equations for PK/PD model development.
    Kristensen NR; Madsen H; Ingwersen SH
    J Pharmacokinet Pharmacodyn; 2005 Feb; 32(1):109-41. PubMed ID: 16215845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling.
    Meibohm B; Derendorf H
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):401-13. PubMed ID: 9352388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples.
    Fattinger KE; Verotta D
    J Pharmacokinet Biopharm; 1995 Dec; 23(6):581-610. PubMed ID: 8733948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconvolution Analysis by Non-linear Regression Using a Convolution-Based Model: Comparison of Nonparametric and Parametric Approaches.
    Gomeni R; Bressolle-Gomeni F
    AAPS J; 2019 Dec; 22(1):9. PubMed ID: 31820258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditioning on certain random events associated with statistical variability in PK/PD.
    Beal SL
    J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):213-43. PubMed ID: 16283533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of meixner functions in estimation of Volterra kernels of nonlinear systems with delay.
    Asyali MH; Juusola M
    IEEE Trans Biomed Eng; 2005 Feb; 52(2):229-37. PubMed ID: 15709660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples.
    Bauer RJ; Guzy S; Ng C
    AAPS J; 2007 Mar; 9(1):E60-83. PubMed ID: 17408237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The identification of nonlinear biological systems: Volterra kernel approaches.
    Korenberg MJ; Hunter IW
    Ann Biomed Eng; 1996; 24(4):250-68. PubMed ID: 8841729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volterra Kernels Assessment via Time-Delay Neural Networks for Nonlinear Unsteady Aerodynamic Loading Identification.
    de Paula NCG; Marques FD; Silva WA
    AIAA J; 2019 Apr; 57(4):1725-1735. PubMed ID: 31534261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous vs. sequential analysis for population PK/PD data II: robustness of methods.
    Zhang L; Beal SL; Sheinerz LB
    J Pharmacokinet Pharmacodyn; 2003 Dec; 30(6):405-16. PubMed ID: 15000422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect pharmacodynamic response models do not require any parametric pharmacokinetic model to be fitted to effect-time data.
    Piotrovsky VK
    Methods Find Exp Clin Pharmacol; 1997 Dec; 19(10):723-9. PubMed ID: 9542723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.